Navitas Life Sciences re-affirms its commitment to transforming healthcare while focusing on patient centricity this World Alzheimer’s Day (September 21st). We support small to large pharma, biotech and devices companies, generics manufacturers, and U.S federal agencies like the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC) and The U.S. Department of Defense (DoD), delivering platform-driven full-service Clinical, Regulatory and Safety solutions and services.
World Alzheimer’s Day 2022
The theme for this World Alzheimer’s day “Know Dementia, Know Alzheimer’s” focusses on diagnosing dementia, understanding the symptoms and finding suitable treatment options.
Efficient Clinical Trial and Registry Support
A technology led full-service CRO, Navitas Life Sciences has 30+ years of rich experience across 550+ phase I-IV clinical trials, 20+ therapeutic areas, 2 ISO 27001- compliant Data Centers and 40+ successful GCP/non-GCP audits. Our trial expertise is augmented by our proprietary OneClinical® Analytics, a platform that delivers trial oversight and key data insights that aid in better decision making for efficient clinical trial management.
At the core of our clinical trials is our unflinching focus on ensuring patient centricity, utilizing the right technology to move from concept to impact with the patient at heart. We have embraced a company wide approach to participating in an emerging ecosystem where the patients in a trial are better connected and drive their preferred initiatives.
3 Ways We Ensure Patient Centricity
1) Including Patient Needs in the Study Design: The needs of the patients and the support required is included in the study design. A single procedure may not be a cause of discomfort for the patient, but when it is coupled with stringent regimens, it can be a cause of discomfort, if it hasn’t been well planned out.
For example, a blood sample collection may not be a cause of concern, unless there are multiple samples to be collected at specific intervals. This requires effective support for transportation, food, or even a place to stay, so that study participants have limited discomfort. A well thought out plan, with patient experience in mind help in tailoring suitable supporting measures, even before the start of the study.
Patient centricity is a focus not only for patients who take part in the study but is a focus for multiple patients who will use the drug product when it reaches the market.
2) Building Patient Understanding and Trust: Patients and volunteers of the study are made to understand the full journey that they will be a part of. By explaining the entire process, doctors and patients understand the various stages, which will help patients better explain their needs and symptoms.
It is not only during the start of the study but at various points during the course of the study that patient insights need to be gained to build effective trials.
Strong Focus on Patient Convenience - Navitas Life Sciences has always been sensitive to patients’ needs and requirements, going the extra mile to accommodate them. Instead of looking outside, we look within, building a strong culture of doing more for patients.
3) Determined Digital Drive: The use of digital tools for better patient engagement has helped in elevating patient experience and supported improved patient retention.
Patient Engagement with digital tools
Digital tools are used to engage with patients better, and to provide them with the assistance they need. This has improved interactions with patients and helped address their concerns.
Navitas Life Sciences takes a holistic approach to patient care, going beyond patient access to sites, adherence to medication and symptom checks to building healthy and meaningful journeys to improved health.
Full Service Clinical Trial Support to assess a Medical Device on Patients with Alzheimer’s Disease
Our client, a US based company, needed full service clinical trial operation and strategy support for the design and execution of a medical device clinical trial in subjects with mild cognitive impairment and Alzheimer’s Disease.
Their specific goals included:
- Study protocol development
- Multiple global site selection
- Database setup
- Creation of study documents
- Management of 12 sites across 3 countries
- Management of cross-functional vendors
- Clinical Monitoring and Regulatory Support
- Support Database Lock
- Statistical Analysis
- Preparation of clinical study report
- Audit Readiness of Sites
Download the Case Study and learn how we worked seamlessly with our client to deliver efficient and effective full-service clinical trial support for this study.